ABL Diagnostics (XPAR:ABLD) Other Net Income (Loss) : €0.62 Mil (TTM As of Jun. 2023)

View and export this data going back to 1989. Start your Free Trial

What is ABL Diagnostics Other Net Income (Loss)?

ABL Diagnostics's Other Net Income (Loss) for the six months ended in Jun. 2023 was €0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2023 was €0.62 Mil.

ABL Diagnostics's quarterly Other Net Income (Loss) increased from Jun. 2022 (€0.00 Mil) to Dec. 2022 (€0.62 Mil) but then declined from Dec. 2022 (€0.62 Mil) to Jun. 2023 (€0.00 Mil).

ABL Diagnostics's annual Other Net Income (Loss) stayed the same from Dec. 2020 (€0.00 Mil) to Dec. 2021 (€0.00 Mil) but then increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.00 Mil).

ABL Diagnostics Other Net Income (Loss) Historical Data

The historical data trend for ABL Diagnostics's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Diagnostics Other Net Income (Loss) Chart

ABL Diagnostics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Other Net Income (Loss)

Get a 7-Day Free Trial

ABL Diagnostics Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	0.62	-

ABL Diagnostics Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.62 Mil.

ABL Diagnostics Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of ABL Diagnostics's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

ABL Diagnostics (XPAR:ABLD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ABL Diagnostics (XPAR:ABLD) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

N/A

Address

72c, rue de, WOIPPY, Thionville, FRA, 57140

Website

https://www.abldiagnostics.com

ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.

ABL Diagnostics (XPAR:ABLD) Headlines

No Headlines